From January 2019 to February 2021, 28 patients (average age ± standard deviation = 42.54 ± 14.31 years) with advanced STS, treated with nab-paclitaxel plus PD-1 inhibitor, were identified. The gene discussed is PDCD1; the disease is telomere syndrome.